• Politics
  • Diversity, equity and inclusion
  • Financial Decision Making
  • Telehealth
  • Patient Experience
  • Leadership
  • Point of Care Tools
  • Product Solutions
  • Management
  • Technology
  • Healthcare Transformation
  • Data + Technology
  • Safer Hospitals
  • Business
  • Providers in Practice
  • Mergers and Acquisitions
  • AI & Data Analytics
  • Cybersecurity
  • Interoperability & EHRs
  • Medical Devices
  • Pop Health Tech
  • Precision Medicine
  • Virtual Care
  • Health equity

AI Medical Service Raises $42.9M for Endoscopy Tech


The tech could improve the diagnosis of gastrointestinal issues.


Photo/Thumb have been modified. Courtesy of peshkova - stock.adobe.com.

AI Medical Service today announced it raised approximately $42.9 million in Series B funding to advance research and development for artificial intelligence (AI) endoscopies.

The company will use the funding to promote clinical trials, further the development pipeline, acquire more expert personnel, invest in equipment and expand overseas. Further development of its AI technology could allow the company to accelerate towards regulatory approval and improve endoscopic medical care worldwide.

AI Medical Service develops AI technology to improve endoscopic specialists’ diagnosis of gastrointestinal issues in the esophagus, stomach and intestines. Its endoscope AI image analysis software uses training data to analyze endoscope images to support specialists.

“Endoscopic treatment is a medical field that needs to be promoted in society because it leads to the improvement of diagnostic accuracy of diseases,” said Masa Matsumoto, general partner of World Innovation Lab, an investor in the funding round. “However, the industry is facing key hurdles including long hours required for analysis and a shortage of human resources.”

The Tokyo-based company offers its endoscopic AI solution to solve these problems and partners with leading medical institutions to achieve strong results, Matsumoto added.

“The AI Medical Service team is not only powered with exceptional software engineering, but authoritative doctors in the endoscopy space,” said Gen Tsuchikawa, MBA, chief investment officer at Sony Innovation Fund by IGV, another participant in the funding. “We are confident that AI Medical Service will provide breakthrough solutions for various medical institutes and endoscopy doctors that will greatly improve the standard of treatment across the global market.”

Additional funding came from Globis Capital Partners and third-party allocations. The funding brings the Tokyo-based company to $57 million raised since its founding in 2017.

Get the best insights in digital health directly to your inbox.


Ajax Raises $100M, Focused on Advancing Med-Tech

NIH Awards $20M to 5 Research Institutions to Accelerate the Development of Biomedical Health Tech

Mednition Raises $10M for AI-Powered Clinical Decision Support Tool

Related Videos
Image: Ron Southwick, Chief Healthcare Executive
George Van Antwerp, MBA
Edmondo Robinson, MD
Craig Newman
Related Content
© 2024 MJH Life Sciences

All rights reserved.